Senator Judd Gregg and the pharmaceutical industry
Judd Gregg will reportedly be appointed as Sec. of Commerce today.
Here a few data points on pharmaceutical issues.
Author: James Love
Norm setting on copyright limitations and exceptions at WIPO: What is ready?
Over the past several weeks there have been a several cases where some well motivated and knowledgeable persons about copyright policy have expressed criticism of an effort by WIPO to negotiate a treaty for persons who are blind or have other reading disabilities, on the grounds that this is not ambitious enough, and a larger all inclusive treaty on limitations and exceptions should be the target.
Knowledge as a Public Good: remarks at the World Forum on Science and Democracy, held in Belém, Brasil
The following are KEI's January 26, 2009 remarks at the World Forum on Science and Democracy, held in Belém, Brasil, an event that is affiliated with the World Social Forum, which is also taking place in Belém the same week.
Minnesota efforts to control college textbook costs
Jennea Ross’s December 28, 2008 report in the Minneapolis Star Tribune caught my eye:
Campuses across the state try new techniques and technology to fight soaring book prices.
One quote from the story follows:
Until this year, University of Minnesota students taking BioC-3021, a biochemistry class, paid $148 for a single, one-semester textbook.
Then professors got smart.
FDA Priority Review Voucher, KEI comments
KEI filed comments on Friday on the FDA request for comments on the Priority Review Voucher.
FTC Alleges Price Gouging, Monopoly For Baby Medicines
This was the title the Washington Post today gave the AP story.
This was the title of the FTC Press release:
Unbranding Medicines — Harvard workshop on generics
Today I am at Harvard, attending a workshop titled: Unbranding Medicines: the politics, promise, and challenge of generic drugs. This is put on by the Harvard Interfaculty Initiative on Medicines and Society. The program in general is quite impressive, particularly as regards to the depth of experience and knowledge about the generic drug industry, including its early origins.
I was asked to speak about the use of prizes. The slides from my presentation are here:
Compulsory licensing
This is from an exchange on IP-Health.
———–
Dear Aidan and Thomas.
There are several things I could mention about this revised position on compulsory licenses, but I will begin with these.
Pogge and Hollis on the Trade-off between access and incentives
This is a comment on the references to compulsory licensing in the Hollis/Pogge HIF book that are quoted below.
https://www.keionline.org/blogs/2008/11/18/excerpts-from-hif-compulsory-licensing/
Aidan Hollis and Thomas Pogge, The Health Impact Fund, Making New Medicines Accessible for All, A Report of Incentives for Global Health, 2008.
WKO meeting in Vienna on the Internet
On November 25, 2008, I was invited to give a talk in Vienna, at the meeting of the Chamber of Commerce (the WKO). The event was organized by Eva Lichtenberger, a Green Party MEP. Eva also spoke, and gave a great talk, in German. Her slides were in English, and I’ll add them when I can. The outline of my talk is given below.